KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Drobna-Śledzińska M, Maćkowska-Maślak N, Jaksik R, Fijałkowski I, Kosmalska M, Czarny J, Lejman M, Sędek Ł, Szczepański T, Pastorczak A, Derwich K, Witt M, Ntziachristos P, Dawidowska M

Open source

DOI: 10.3324/haematol.2026.300620
Published: 2026 Aug 13
Container: Haematologica
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.300620,
  title = {KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.},
  author = {Drobna-Śledzińska M and Maćkowska-Maślak N and Jaksik R and Fijałkowski I and Kosmalska M and Czarny J and Lejman M and Sędek Ł and Szczepański T and Pastorczak A and Derwich K and Witt M and Ntziachristos P and Dawidowska M},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.300620},
  url = {https://doi.org/10.3324/haematol.2026.300620}
}

RIS

TY  - JOUR
TI  - KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.
AU  - Drobna-Śledzińska M
AU  - Maćkowska-Maślak N
AU  - Jaksik R
AU  - Fijałkowski I
AU  - Kosmalska M
AU  - Czarny J
AU  - Lejman M
AU  - Sędek Ł
AU  - Szczepański T
AU  - Pastorczak A
AU  - Derwich K
AU  - Witt M
AU  - Ntziachristos P
AU  - Dawidowska M
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.300620
UR  - https://doi.org/10.3324/haematol.2026.300620
ER  -

APA

M, D., N, M., R, J., I, F., M, K., J, C., M, L., Ł, S., T, S., A, P., K, D., M, W., P, N., & M, D. (2026). KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.. Haematologica. https://doi.org/10.3324/haematol.2026.300620

Source records

pubmed · retrieved 2026-11-10T18:12:46.835Z